Effects of antithrombin III treatment in vascular injury model of mice

Akiko Maeda1, Kunio Ohta1, Kazuhide Ohta1

  • 1Department of Pediatrics, Angiogenesis and Vascular Development, Graduate School of Medical Science, Kanazawa UniversityDepartment of Pediatrics, National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan.

Insights

Antithrombin III (ATIII) significantly reduced thrombus formation and inflammation after arterial injury in mice. This suggests ATIII may be a potential therapeutic agent for preventing complications following angioplasty, without affecting vascular remodeling.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Balloon angioplasty is used for congenital heart disease stenotic lesions.
  • Restenosis and thrombosis are common post-procedure complications.
  • Mechanisms underlying these complications remain unclear.

Purpose of the Study:

  • To investigate the effects of antithrombin III (ATIII) on inflammation, thrombus formation, and vascular remodeling.
  • To assess ATIII's potential in mitigating complications after arterial injury.

Main Methods:

  • Guidewire-induced femoral artery injury in mice.
  • Administration of ATIII or saline intravenously before injury.
  • Evaluation of thrombus formation, inflammatory cell infiltration (CD11b density), and neointimal proliferation at 72 hours and 28 days post-injury.

Main Results:

  • Saline-treated vessels showed significant thrombus formation 72 hours post-injury; ATIII-treated vessels did not.
  • ATIII treatment markedly reduced inflammatory cell infiltration compared to controls.
  • Neointimal proliferation levels were similar in both groups at 28 days.

Conclusions:

  • High-dose ATIII reduces mural thrombus formation and inflammatory responses after arterial injury.
  • ATIII does not appear to alter the vascular remodeling process.
  • ATIII shows potential for managing arterial injury complications.
Abstract